Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Adicionar filtros








Intervalo de ano
1.
Experimental & Molecular Medicine ; : 445-452, 2006.
Artigo em Inglês | WPRIM | ID: wpr-200504

RESUMO

We investigated the effect of tilianin upon inducible nitric oxide synthesis in the plasma of low-density lipoprotein receptor knock-out (Ldlr-/-) mice fed with high cholesterol diet and in primary peritoneal macrophages of Ldlr-/- mice. High cholesterol diet induced nitric oxide production in the plasma of Ldlr-/- mice. Tilianin reduced the level of nitric oxide (NO) in plasma from Ldlr-/- mice induced by the high cholesterol diet. Tilianin also inhibited the NO production from the primary culture of peritoneal macrophages treated with lipopolysaccharide. The inhibition of NO production was caused by the suppression of inducible nitric oxide synthase (iNOS) gene expression in peritoneal macrophages isolated from Ldlr-/- mice. Moreover, tilianin inhibited the transcriptional activation of iNOS promoter that has NF-kappa B binding element. Thus, these results provide the first evidence that tilianin inhibit iNOS expression and production of NO and may act as a potential anti-inflammatory agent.


Assuntos
Camundongos , Masculino , Animais , Tirosina/análogos & derivados , Distribuição Tecidual , Seio Aórtico/metabolismo , Receptores de LDL/genética , Regiões Promotoras Genéticas/efeitos dos fármacos , Óxido Nítrico Sintase Tipo II/metabolismo , Óxido Nítrico/biossíntese , NF-kappa B/metabolismo , Camundongos Knockout , Inflamação/metabolismo , Glicosídeos/farmacologia , Flavonoides/farmacologia , Regulação para Baixo/efeitos dos fármacos , Aterosclerose/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA